FDA Addresses Retailers Selling E-Cigarettes to Youth

Letters follow an investigation into the sale of unauthorized products. The U.S. Food and Drug Administration (FDA) sent warning letters to 30 retailers and one distributor, following an…

Read More

FDA Proposes Easy-to-Read Medication Guides

Agency seeks to prevent adverse drug reactions and improve health outcomes. The U.S. Food and Drug Administration (FDA) has proposed that patients be provided an easy-to-read one-page guide,…

Read More

FDA Approves Nasal Spray for Emergency Overdose Treatment

Opvee nasal spray addresses respiratory depression, sedation, and low blood pressure. The U.S. Food and Drug Administration (FDA) has given its approval for Opvee—the first nasal spray containing…

Read More

FDA Grants Full Approval for COVID-19 Pill Paxlovid

Pfizer is authorized to sell the drug in the United States. The Food and Drug Administration (FDA) has granted Pfizer’s drug Paxlovid full authorization for use in the…

Read More

White House Seeks Increased Access to Overdose-Reversal Drug

Officials will talk with manufacturers to reduce the cost of naloxone. A spokesperson for the White House Office of National Drug Control Policy (ONDCP) recently said that President…

Read More

FDA Panel Votes for Over-the-Counter Birth Control Pill

The recommendation minimizes the dangers of the side effects. An advisory panel for the Food and Drug Administration (FDA) voted this week to recommend the over-the-counter sale of…

Read More

Abortion Providers Sue to Preserve Mifepristone Access

Senator Lankford responds to FDA limitations on reporting complications from abortions. A group of abortion providers filed a lawsuit this week to lift federal restrictions on mifepristone, an…

Read More

FDA Approves First Vaccine for Respiratory Syncytial Virus

First doses will be available in the Fall.  British drugmaker GlaxoSmithKline (GSK) announced this week that the Food and Drug Administration (FDA) has approved their respiratory syncytial virus…

Read More

FDA Approves Cell Therapy for Blood Cancer Patients

Cell therapy has the potential to reduce the risk of infection after stem cell transplants. The U.S. Food and Drug Administration (FDA) recently approved Omisirge (omidubicel-onlv), a donor-modified…

Read More

FDA Issues Recall for Some CPAP Machines

43 complaints were received on certain Philips models, leading to Class I recall. The Food and Drug Administration (FDA) issued a Class I recall, the most serious type,…

Read More

Back to top
FE3